A 45-year-old woman with type 2 diabetes mellitus presents for routine follow-up. Her physician prescribes exenatide, a GLP-1 receptor agonist, to improve glycemic control. The drug increases insulin secretion and decreases glucagon release in a glucose-dependent manner. Through which signal transduction mechanism does GLP-1 receptor activation primarily lead to insulin secretion in pancreatic beta cells?
G-protein coupled receptors
Practice Questions
Tyrosine kinase receptors
Practice Questions
Second messenger systems (cAMP, cGMP, Ca2+)
Practice Questions
MAP kinase pathways
Practice Questions
JAK-STAT pathway
Practice Questions
PI3K-Akt pathway
Practice Questions
Nuclear receptor signaling
Practice Questions
WNT signaling pathway
Practice Questions
Notch signaling pathway
Practice Questions
Hedgehog signaling pathway
Practice Questions
TGF-β/SMAD signaling
Practice Questions
NF-κB signaling
Practice Questions
Dysregulation in disease states
Practice Questions
Pharmacological targeting of signaling pathways
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Scan to download app
Enter your email to get your 85% OFF code and unlock the full USMLE question bank on the app.